TRAICK Raises $1.5M Seed Funding to Advance AI-Powered Medical Imaging for Early Diagnosis
TRAICK, a London- and Istanbul-based health-tech startup developing AI-powered medical imaging solutions for early and accurate diagnosis of thyroid and related conditions, has raised $1.5 million in seed funding to accelerate product development, expand clinical validation efforts, and strengthen its market presence in Europe and the UK. The company’s fundraising highlights growing investor interest in artificial intelligence applications that improve diagnostic accuracy and reduce time-to-diagnosis for clinicians and patients.
Founded in 2021, TRAICK has built an AI-driven platform designed to enhance the analysis of ultrasound images for thyroid nodules and potentially other soft-tissue conditions. The solution employs advanced machine-learning algorithms to assess imaging data, delivering malignancy risk scores and clinical insights in seconds, with the aim of supporting radiologists and healthcare professionals in making faster, more informed decisions. The company’s technology addresses a long-standing challenge in medical imaging, where manual interpretation of ultrasound scans can be time-consuming and prone to inter-observer variability.
The seed round was led by iLab Ventures, a strategic investor focused on AI and deep technology startups, marking its first technology investment within its portfolio. iLab’s participation reflects confidence in TRAICK’s vision of transforming diagnostic imaging through scalable AI solutions. Backers within iLab see significant potential in leveraging artificial intelligence to augment clinical workflows and improve diagnostic outcomes, particularly as demand grows for tools that can assist in early detection of serious conditions.
According to TRAICK’s leadership, the fresh capital will be used to accelerate research and development, advance regulatory certification processes, and broaden commercial outreach. A critical element of the funding is aimed at boosting the company’s capabilities in imaging analysis and certification readiness — foundational steps toward bringing the technology to clinical healthcare settings across Europe and the United Kingdom. Leadership says that expanding into these markets is a priority, as healthcare systems increasingly embrace AI-supported tools to enhance patient care.
TRAICK emphasized that the seed investment will also support efforts to finalize product certification and expand partnerships with clinical and technology collaborators. The company’s goal is to make AI-enhanced imaging more accessible to healthcare providers while establishing a new standard for early diagnosis solutions. TRAICK’s team believes that its platform can significantly reduce dependency on subjective interpretation and increase the speed and reliability of diagnostic outcomes.
TRAICK’s founders include experienced professionals with backgrounds in medical imaging, artificial intelligence, and healthcare technology, and they have built the company with a focus on clinical utility and real-world applicability. By streamlining the ultrasound analysis workflow and reducing variability between human interpretations, the company’s technology aims to improve confidence in early diagnosis, particularly for conditions where early detection can significantly influence treatment success rates.
The global demand for AI-enhanced medical imaging tools is rising rapidly as healthcare systems worldwide seek solutions that can improve diagnostic speed and outcomes while alleviating pressure on overburdened clinical workflows. TRAICK’s platform positions itself at the intersection of this trend by offering a scalable, AI-driven decision support system that augments radiologists’ expertise with data-driven risk assessments. Its focus on rapid, accurate analysis has the potential to reduce unnecessary biopsies and accelerate clinical decision-making, especially in busy diagnostic environments.
With the backing of iLab Ventures and fresh seed capital, TRAICK is poised to deepen its impact in the medical diagnostics space. The company’s expanded R&D efforts and push toward broader clinical adoption signal a commitment to developing tools that not only assist clinicians but also improve patient experiences by enabling earlier, more reliable detection of critical health conditions.
TRAICK’s funding milestone highlights the rising investor interest in AI applications across healthcare and reflects growing recognition of the role that advanced imaging analytics can play in improving clinical efficiency and patient outcomes. As the startup continues to scale and refine its technology, it is set to contribute to the evolution of AI-assisted diagnostics in the years ahead.
